Skip to content

Shattuck Labs, Inc. STTK Proceeds From Sale And Maturity Of Available For Sale Securities

Proceeds From Sale And Maturity Of Available For Sale Securities at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s proceeds from sale and maturity of available for sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s proceeds from sale and maturity of available for sale securities?
Shattuck Labs, Inc. (STTK) reported proceeds from sale and maturity of available for sale securities of $23.92M in Q1 2026.
How has Shattuck Labs, Inc.'s proceeds from sale and maturity of available for sale securities changed year-over-year?
Shattuck Labs, Inc.'s proceeds from sale and maturity of available for sale securities increased by 53.3% year-over-year, from $15.6M to $23.92M.
What is the long-term trend for Shattuck Labs, Inc.'s proceeds from sale and maturity of available for sale securities?
Over 3 years (2021 to 2024), Shattuck Labs, Inc.'s proceeds from sale and maturity of available for sale securities has grown at a -25.0% compound annual growth rate (CAGR), from $201.58M to $85.1M.